Harrow, Inc.

HROW ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Assets
Cash & Equivalents $72.9M $47.2M $74.1M $96.3M $42.2M $4.1M $4.7M $6.8M
Accounts Receivable $110.9M $116.4M $36.3M $6.2M $4.5M $2.7M $2.0M $1.9M
Inventory $13.5M $10.7M $10.9M $6.5M $4.2M $4.0M $3.3M $1.8M
Total Current Assets $211.8M $189.7M $139.5M $118.3M $60.7M $41.0M $36.0M $32.8M
Property, Plant & Equipment $3.3M $3.7M $3.5M $3.5M $3.1M $3.9M $5.4M $6.4M
Goodwill $332.0K $332.0K $332.0K $332.0K $332.0K $332.0K $332.0K $2.2M
Intangible Assets (Excl. Goodwill) $175.2M $184.9M $159.9M $23.7M $15.8M $1.9M $2.3M $3.1M
Total Assets $399.5M $389.0M $312.2M $157.4M $98.3M $57.5M $59.1M $49.5M
Liabilities
Accounts Payable $35.4M $38.8M $24.6M $13.8M $6.3M $3.9M $7.7M $6.3M
Total Current Liabilities $96.3M $91.3M $49.3M $18.6M $9.7M $10.8M $12.3M $11.9M
Long-Term Debt $250.0M $262.7M $246.7M $151.8M $103.0M $20.0M — $23.5M
Total Liabilities $347.4M $319.7M $241.8M $130.1M $87.4M $30.6M $31.7M $24.7M
Stockholders' Equity
Retained Earnings $-156.5M $-151.4M $-133.9M $-109.5M $-95.4M $-77.4M $-74.0M $-74.2M
Total Stockholders' Equity $52.4M $69.7M $70.8M $27.6M $11.3M $27.2M $27.7M $24.8M
← Newer Page 1 of 2 Older →